论文部分内容阅读
一九八三年十月十三日,国发[1983]160号文《国务院批转国家医药管理局关于中药工作问题报告的通知》。国务院通知中指出:“中药工作是关系我国十亿人民保健医疗事业的大事。当前部分中药供应紧缺,影响防病治病的状况,应当引起各级人民政府的注意。要加强对中药工作的领导,恢复和健全药材专业公司的体制。对于供应紧缺的品种,除了属于国家禁猎和重点保护的动物外,其余品种必须采取有效措施,积极发展生产,尽快解决。对中药市场要加强管理,严禁哄抬药价和破坏中药资源。”通知中又强调指出:“中药材是商品,生产、流通、消费的一切政策措施必须符合经济规律,但中药材又不同于一般农副产品,是防病治病的特殊商品,必须由药材公司统一计划、统一管理、统一经营。二类药材应由药材公司严格按照计划和牌价统一收购、加工、调拨和供应出口,除药材公司委托供销社代购外,其它部门和个人均不得插手经营。销区的药材经营单位不准高价抢购或到产地抬价抢购紧缺药材。完成派购任务后的二类药材,可以实行浮动价格,按物价管理权限,经过批准执行。”望各地认真贯彻执行。本刊现将“关于中药工作问题的报告”全文予以发表。
On October 13, 1983, Guofa [1983] No. 160 “The State Council approved the notification of the State Pharmaceutical Administration’s report on the work of Chinese medicine.” The State Council notice pointed out: “The work of Chinese medicine is a major issue that concerns China’s one billion people’s health care business. The current shortage of some traditional Chinese medicines, which affects the state of preventing and curing diseases, should attract the attention of people’s governments at all levels. It is necessary to strengthen the leadership of Chinese medicine work. To restore and improve the system of medicinal herbs specialists, for species that are in short supply, in addition to animals that are banned from national hunting and key protection, other varieties must take effective measures to actively develop production and resolve them as soon as possible. The price of drugs has been increased and the resources of Chinese medicines have been destroyed.” The notice also emphasized that: “Chinese herbal medicines are commodities, and all policy measures for production, circulation, and consumption must comply with the economic laws, but Chinese herbal medicines are different from general agricultural and sideline products, and are used to prevent and treat diseases. The special commodities must be uniformly planned, managed, and managed by the herbal medicine company. The second category of medicinal materials should be acquired, processed, allocated and supplied by the herbal medicine company in strict accordance with the plan and the price of the license. In addition to the purchasing and sales agency commissioned by the medicinal materials company, other departments Both individuals and individuals are not allowed to enter into business. The price of the place of origin rushed to purchase medicines that were in short supply, and the second category of medicines after the completion of the purchase task could be implemented at floating prices and approved by the price management authority. The journal now publishes the full text of the “Report on Problems Concerning Chinese Materia Medica Work”.